These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 219130)

  • 1. A role for elevated H-2 antigen expression in resistance to neoplasia caused by radiation-induced leukemia virus. Enhancement of effective tumor surveillance by killer lymphocytes.
    Meruelo D
    J Exp Med; 1979 Apr; 149(4):898-909. PubMed ID: 219130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of H-2 antigen expression on thymocytes during leukemia development by radiation leukemia virus.
    Katz E; Peled A; Haran-Ghera N
    Leuk Res; 1985; 9(10):1219-25. PubMed ID: 2999517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased synthesis and expression of H-2 antigens on thymocytes as a result of radiation leukemia virus infection: a possible mechanism for H-2 linked control of virus-induced neoplasia.
    Meruelo D; Nimelstein SH; Jones PP; Lieberman M; McDevitt HO
    J Exp Med; 1978 Feb; 147(2):470-87. PubMed ID: 75239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro generation of cytotoxic lymphocytes against radiation- and radiation leukemia virus-induced tumors. III. Suppression of anti-tumor immunity in vitro by lymphocytes of mice undergoing radiation leukemia virus-induced leukemogenesis.
    Yefenof E; Meidav A; Kedar E
    J Exp Med; 1980 Dec; 152(6):1473-83. PubMed ID: 6256461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to RadLV-induced leukemia: non-participation of splenic natural killer cells.
    St-Pierre Y; Hugo P; Lemieux S; Lussier G; Potworowski EF
    Leukemia; 1988 Aug; 2(8):551-3. PubMed ID: 2842550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H-21-linked control of immunological resistance to viral leukemogenesis as a response to preleukemic cells.
    Lonai P; Katz E; Peled A; Haran-Ghera N
    Immunogenetics; 1981 Mar; 12(5-6):423-32. PubMed ID: 6260638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H-2D control of leukaemia susceptibility: mechanism and implications.
    Meruelo D
    J Immunogenet; 1980 Feb; 7(1):81-90. PubMed ID: 6154752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo stimulation of H-2Dd expression following RadLV infection of thymocytes: increased transcription and DNA-binding activity to sequences 5' of the Dd gene.
    Brown GD; Nobunaga T; Morris DR; Meruelo D
    Res Immunol; 1991; 142(5-6):431-40. PubMed ID: 1754716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell surface antigens of radiation leukemia virus-induced BALB/c leukemias defined by syngeneic cytotoxic T lymphocytes.
    Kaneko Y; Oettgen HF; Obata Y; Nakayama E
    Jpn J Cancer Res; 1989 Mar; 80(3):257-64. PubMed ID: 2542207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional properties of Ly 11.2 lymphocytes: a role for these cells in leukemia?
    Meruelo D; Paolino A; Flieger N; Dworkin J; Offer M; Hirayama N; Ovary Z
    J Immunol; 1980 Dec; 125(6):2719-26. PubMed ID: 6253569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of antigens coded in murine leukemia viruses on thymocytes of allogeneic donor origin in AKR mice following syngeneic or allogeneic bone marrow transplantation.
    Wustrow TP; Good RA
    Cancer Res; 1985 Dec; 45(12 Pt 1):6428-35. PubMed ID: 2998600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A highly leukemogenic radiation leukemia virus isolate is a thymotropic, immunosuppressive retrovirus with a unique RNA structure.
    Ben David Y; Kotler M; Yefenof E
    Int J Cancer; 1987 Apr; 39(4):492-7. PubMed ID: 2435664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of potential lymphoma-inducing cells in mice sensitive or resistant to lymphomagenesis by radiation leukemia virus variants.
    Gokhman I; Peled A; Haran-Ghera N
    Cancer Res; 1990 May; 50(9):2554-61. PubMed ID: 2158393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased H-2Dd expression following infection by a molecularly cloned ecotropic MuLV.
    Brown GD; Egan G; Dowling T; Meruelo D
    Immunogenetics; 1990; 31(2):94-103. PubMed ID: 2154401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.
    Herberman RB; Holden HT; Ting CC; Lavrin DL; Kirchner H
    Cancer Res; 1976 Feb; 36(2 pt 2):615-21. PubMed ID: 56223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral specificity of H-2-restricted T killer cells directed against syngeneic tumors induced by Gross, Friend, or Rauscher leukemia virus.
    Plata F; Lilly F
    J Exp Med; 1979 Nov; 150(5):1174-86. PubMed ID: 91655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation leukemia virus-induced thymic lymphomas express a restricted repertoire of T-cell receptor V beta gene products.
    Sen-Majumdar A; Weissman IL; Hansteen G; Marian J; Waller EK; Lieberman M
    J Virol; 1994 Feb; 68(2):1165-72. PubMed ID: 8289345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro infection of lymphoid cells by thymotropic radiation leukemia virus grown in vitro.
    Haas M; Hilgers J
    Proc Natl Acad Sci U S A; 1975 Sep; 72(9):3546-50. PubMed ID: 171665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.